Literature DB >> 25009264

Aging decreases L-type calcium channel currents and pacemaker firing fidelity in substantia nigra dopamine neurons.

Sarah Y Branch1, Ramaswamy Sharma2, Michael J Beckstead3.   

Abstract

Substantia nigra dopamine neurons are involved in behavioral processes that include cognition, reward learning, and voluntary movement. Selective deterioration of these neurons is responsible for the motor deficits associated with Parkinson's disease (PD). Aging is the leading risk factor for PD, suggesting that adaptations occurring in dopamine neurons during normal aging may predispose individuals to the development of PD. Previous studies suggest that the unique set of ion conductances that drive spontaneous, rhythmic firing of action potentials could predispose substantia nigra dopamine neurons to selective neurodegeneration. Here we show, using patch-clamp electrophysiological recordings in brain slices, that substantia nigra dopamine neurons from mice 25-30 months of age (old) have comparable membrane capacitance and input resistance to neurons from mice 2-7 months of age (young). However, neurons from old mice exhibit slower firing rates, narrower spike widths, and more variable interspike intervals compared with neurons from young mice. Dopamine neurons from old mice also exhibit smaller L-type calcium channel currents, providing a plausible mechanism that likely contributes to the changes in impulse activity. Age-related decrements in the physiological function of dopamine neurons could contribute to the decrease in voluntary movement and other dopamine-mediated behaviors observed in aging populations. Furthermore, as pharmacological antagonism of L-type calcium channels has been proposed as a potential treatment for the early stages of PD, our results could point to a limited temporal window of opportunity for this therapeutic intervention.
Copyright © 2014 the authors 0270-6474/14/349310-09$15.00/0.

Entities:  

Keywords:  L-type calcium channels; dopamine; firing; mouse; pacemaking

Mesh:

Substances:

Year:  2014        PMID: 25009264      PMCID: PMC4087208          DOI: 10.1523/JNEUROSCI.4228-13.2014

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  54 in total

1.  Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR.

Authors:  Michael W Pfaffl; Graham W Horgan; Leo Dempfle
Journal:  Nucleic Acids Res       Date:  2002-05-01       Impact factor: 16.971

2.  Long-term K+ channel-mediated dampening of dopamine neuron excitability by the antipsychotic drug haloperidol.

Authors:  Junghyun Hahn; Tonia E Tse; Edwin S Levitan
Journal:  J Neurosci       Date:  2003-11-26       Impact factor: 6.167

Review 3.  Regulation of cell death: the calcium-apoptosis link.

Authors:  Sten Orrenius; Boris Zhivotovsky; Pierluigi Nicotera
Journal:  Nat Rev Mol Cell Biol       Date:  2003-07       Impact factor: 94.444

4.  Pacemaking in dopaminergic ventral tegmental area neurons: depolarizing drive from background and voltage-dependent sodium conductances.

Authors:  Zayd M Khaliq; Bruce P Bean
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

Review 5.  Neuroprotective and neurorestorative strategies for Parkinson's disease.

Authors:  Ted M Dawson; Valina L Dawson
Journal:  Nat Neurosci       Date:  2002-11       Impact factor: 24.884

Review 6.  Dopamine and the regulation of cognition and attention.

Authors:  André Nieoullon
Journal:  Prog Neurobiol       Date:  2002-05       Impact factor: 11.685

7.  The acid test of fluoride: how pH modulates toxicity.

Authors:  Ramaswamy Sharma; Masahiro Tsuchiya; Ziedonis Skobe; Bakhos A Tannous; John D Bartlett
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

8.  Rate of cell death in parkinsonism indicates active neuropathological process.

Authors:  P L McGeer; S Itagaki; H Akiyama; E G McGeer
Journal:  Ann Neurol       Date:  1988-10       Impact factor: 10.422

9.  Influence of R-type (Cav2.3) and t-type (Cav3.1-3.3) antagonists on nigral somatodendritic dopamine release measured by microdialysis.

Authors:  F Bergquist; H Nissbrandt
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

10.  Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum.

Authors:  John W Haycock; Laurence Becker; Lee Ang; Yoshiaki Furukawa; Oleh Hornykiewicz; Stephen J Kish
Journal:  J Neurochem       Date:  2003-11       Impact factor: 5.372

View more
  26 in total

1.  Lower Affinity of Isradipine for L-Type Ca2+ Channels during Substantia Nigra Dopamine Neuron-Like Activity: Implications for Neuroprotection in Parkinson's Disease.

Authors:  Nadine J Ortner; Gabriella Bock; Antonios Dougalis; Maria Kharitonova; Johanna Duda; Simon Hess; Petronel Tuluc; Thomas Pomberger; Nadia Stefanova; Florian Pitterl; Thomas Ciossek; Herbert Oberacher; Henning J Draheim; Peter Kloppenburg; Birgit Liss; Jörg Striessnig
Journal:  J Neurosci       Date:  2017-06-07       Impact factor: 6.167

2.  Progressively disrupted somatodendritic morphology in dopamine neurons in a mouse Parkinson's model.

Authors:  William B Lynch; Christopher W Tschumi; Amanda L Sharpe; Sarah Y Branch; Cang Chen; Guo Ge; Senlin Li; Michael J Beckstead
Journal:  Mov Disord       Date:  2018-11-15       Impact factor: 10.338

3.  Ionic currents influencing spontaneous firing and pacemaker frequency in dopamine neurons of the ventrolateral periaqueductal gray and dorsal raphe nucleus (vlPAG/DRN): A voltage-clamp and computational modelling study.

Authors:  Antonios G Dougalis; Gillian A C Matthews; Birgit Liss; Mark A Ungless
Journal:  J Comput Neurosci       Date:  2017-04-03       Impact factor: 1.621

4.  Neurogranin binds α-synuclein in the human superior temporal cortex and interaction is decreased in Parkinson's disease.

Authors:  Andrew O Koob; Gideon M Shaked; Andreas Bender; Alejandro Bisquertt; Edward Rockenstein; Eliezer Masliah
Journal:  Brain Res       Date:  2014-10-19       Impact factor: 3.252

Review 5.  New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders.

Authors:  Heather M Wilkins; Jill K Morris
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

6.  N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice.

Authors:  Rosalia Crupi; Daniela Impellizzeri; Marika Cordaro; Rosalba Siracusa; Giovanna Casili; Maurizio Evangelista; Salvatore Cuzzocrea
Journal:  Mol Neurobiol       Date:  2018-03-19       Impact factor: 5.590

7.  Female mice are resilient to age-related decline of substantia nigra dopamine neuron firing parameters.

Authors:  Rebecca D Howell; Sergio Dominguez-Lopez; Sarah R Ocañas; Willard M Freeman; Michael J Beckstead
Journal:  Neurobiol Aging       Date:  2020-08-03       Impact factor: 4.673

8.  Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease.

Authors:  Sarah Y Branch; Cang Chen; Ramaswamy Sharma; James D Lechleiter; Senlin Li; Michael J Beckstead
Journal:  J Neurosci       Date:  2016-04-06       Impact factor: 6.167

9.  Dopamine Transporter Is a Master Regulator of Dopaminergic Neural Network Connectivity.

Authors:  Douglas R Miller; Dylan T Guenther; Andrew P Maurer; Carissa A Hansen; Andrew Zalesky; Habibeh Khoshbouei
Journal:  J Neurosci       Date:  2021-05-12       Impact factor: 6.167

10.  Age-dependent alterations in key components of the nigrostriatal dopaminergic system and distinct motor phenotypes.

Authors:  Jiang-Peng Fan; Hui-Zhen Geng; Ya-Wei Ji; Tao Jia; Jennifer B Treweek; An-An Li; Chun-Yi Zhou; Viviana Gradinaru; Cheng Xiao
Journal:  Acta Pharmacol Sin       Date:  2021-07-09       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.